🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multi-center real-world study, in which patients who meet the inc...
Status
Recruiting
Location
The Fourth Hospital of Hebei Medical University
Start Date
2024-01-02
Trial ID
NCT06217185
Treatments Being Tested
This is an open, prospective and interventional clinical study. Patients wi...
Status
Unknown
Location
The First Affiliated Hospital of Xi'an Jiaotong University
Start Date
2021-01-01
Trial ID
NCT05429684
This study intends to conduct a small, prospective, single-center clinical ...
Status
Unknown
Location
Tongji Hospital Affiliated of Tongji Medical College Huazhong University of Science and Technology
Start Date
2023-11-30
Trial ID
NCT06152822
Treatments Being Tested
This study is a prospective, single-center, open-label, umbrella-shaped pha...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-05-01
Trial ID
NCT04355858
Capecitabine combined with pyrotinib is the standard protocol for HR+/HER2+...
Status
Recruiting
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2020-10-14
Trial ID
NCT04646759
Treatments Being Tested
To evaluate the efficacy and safety of pyrotinib plus capecitabine in HER2-...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-06-15
Trial ID
NCT06475443
Treatments Being Tested
HER2-targeted therapy after the failure of trastuzumab treatment has become...
Status
Unknown
Location
Sun Yat Sen Memorial Hospital，Sun Yat sen University
Start Date
2020-09-09
Trial ID
NCT04681911
Treatments Being Tested
This study evaluates the efficacy and safety of SRT combined with pyrotinib...
Status
Unknown
Location
Jiangxi Cancer Hospital of Nanchang University
Start Date
2022-03-01
Trial ID
NCT05042791
Treatments Being Tested
Objective: To explore the efficacy and safety of Pyrotinib, trastuzumab sub...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07-15
Trial ID
NCT06483386
Treatments Being Tested
This study is a single-arm, exploratory clinical trial, aiming to include p...
Status
Not Yet Recruiting
Location
Fujian Cancer Hosptial
Start Date
2026-09-30
Trial ID
NCT07766772
Treatments Being Tested